Pasar al contenido principal

Biomarcadores chivatos de alteraciones en el Alzheimer de la vía apoE y el APP, su validación en modelos celulares (CHIVAT-AD)

PI22/01329

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i en Salud
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION DE LA COMUNIDAD VALENCIANA PARA LA GESTION DEL INST. INV. SANIT. Y BIOMEDICA DE ALICANTE
Centro realización FUNDACION DE LA COMUNIDAD VALENCIANA PARA LA GESTION DEL INST. INV. SANIT. Y BIOMEDICA DE ALICANTE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NMDARs in Alzheimer's Disease: Between Synaptic and Extrasynaptic Membranes

  • Escamilla, Sergio
  • Sáez-Valero, Javier
  • Cuchillo-Ibáñez, Inmaculada
N-methyl-D-aspartate receptors (NMDARs) are glutamate receptors with key roles in synaptic communication and plasticity. The activation of synaptic NMDARs initiates plasticity and stimulates cell survival. In contrast, the activation of extrasynaptic NMDARs can promote cell death underlying a potential mechanism of neurodegeneration occurring in Alzheimer's disease (AD). The distribution of synaptic versus extrasynaptic NMDARs has emerged as an important parameter contributing to neuronal dysfunction in neurodegenerative diseases including AD. Here, we review the concept of extrasynaptic NMDARs, as this population is present in numerous neuronal cell membranes but also in the membranes of various non-neuronal cells. Previous evidence regarding the membranal distribution of synaptic versus extrasynaptic NMDRs in relation to AD mice models and in the brains of AD patients will also be reviewed., This research was funded by Fondo de Investigaciones Sanitarias (PI22-01329, co-funded by the Fondo Europeo de Desarrollo Regional, FEDER “Investing in your future”), CIBERNED (Instituto de Salud Carlos III, Spain), ISABIAL (Instituto de Investigación Sanitaria y Biomédica de Alicante), and the Direcció General de Ciència i Investigació, Generalitat Valenciana (AICO/2021/308). We acknowledge financial support from the Spanish Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación, through the “Severo Ochoa” Programme for Centres of Excellence in R&D (CEX2021-001165-S). Sergio Escamilla is funded by the Instituto Carlos III de Madrid (PFIS fellowship)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Risk for COVID-19 Vulnerability in Patients with Inflammatory Bowel Disease: Assessing Alterations in ACE2 and TMPRSS2

  • Sáez-Leyva, Jorge
  • Lennol, Matthew P.
  • Avilés-Granados, Carlos
  • García-Ayllón, María-Salud
  • Sáez-Valero, Javier
Chronic inflammatory conditions often involve the dysregulation of key enzymes, including serine proteases such as transmembrane serine protease 2 (TMPRSS2) and the angiotensin converting enzyme 2 (ACE2), which are key proteins implicated in the cellular entry mechanism of SARS-CoV-2. It remains uncertain whether the gastrointestinal symptoms observed in COVID-19 patients result from direct viral infection of the gastrointestinal tract, a process that may be exacerbated by altered expression of ACE2 or TMPRSS2. In this review, we explore the interplay among ACE2 and TMPRSS2 in the context of inflammatory bowel disease (IBD), including their roles in disease pathology and response to therapy. We also examine methodological approaches for assessing whether protease alterations contribute to increased susceptibility to infection, considering that TMPRSS2 exists in inactive (zymogen) and active forms. Furthermore, while membrane-bound ACE2 facilitates viral entry, soluble ACE2 fragments may act as decoys, preventing virus–receptor interaction. Therefore, the interpretation of changes in full-length versus cleaved forms of ACE2 and related enzymes is critical for understanding vulnerability to SARS-CoV-2 infection., This work was supported by grants from the Fondo de Investigaciones Sanitarias (PI22/01329, co-funded by the Fondo Europeo de Desarrollo Regional, FEDER “Investing in your future”), CIBERNED (Instituto de Salud Carlos III, Spain), from the Direcció General de Ciència i Investigació, Generalitat Valenciana (AICO/2021/308) and “Severo Ochoa” Program for Centers of Excellence in R&D (CEX2021-001165-S). CAG is supported by a predoctoral contract (PRE2022-104182) funded by the Agencia Estatal de Investigación (AEI) and the Ministerio de Ciencia e Innovación (MCIN) under the Plan Estatal de I + D + I 2021–2023, co-funded by the European Social Fund (FSE)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed